Real-time enrollment status for this geographic atrophy secondary to age-related macular degeneration clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:26 PM UTC
| NCT Number | NCT07392255 |
| Recruiting Status | Recruiting |
| Condition | Geographic Atrophy Secondary to Age-related Macular Degeneration |
| Phase | Clinical Trial |
| Target Enrollment | 75 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Complement Therapeutics |
| Last Updated on CT.gov | June 22, 2026 (3 weeks ago) |
As of July 13, 2026: Clinical trial NCT07392255 is currently recruiting participants. This clinical trial study for geographic atrophy secondary to age-related macular degeneration is actively seeking new participants at 4 locations across the United States. The study is sponsored by Complement Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07392255 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07392255 was last updated 3 weeks ago (June 22, 2026). HelloStudys verifies this status automatically.